BioGaia AB (publ)

Stockholm Stock Exchange BIOG-B.ST

BioGaia AB (publ) Free Cash Flow for the year ending December 31, 2023: USD 37.23 M

BioGaia AB (publ) Free Cash Flow is USD 37.23 M for the year ending December 31, 2023, a 29.52% change year over year. Free cash flow is the amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.
  • BioGaia AB (publ) Free Cash Flow for the year ending December 31, 2022 was USD 28.75 M, a 21.17% change year over year.
  • BioGaia AB (publ) Free Cash Flow for the year ending December 31, 2021 was USD 23.73 M, a -4.59% change year over year.
  • BioGaia AB (publ) Free Cash Flow for the year ending December 31, 2020 was USD 24.87 M, a 114.76% change year over year.
  • BioGaia AB (publ) Free Cash Flow for the year ending December 31, 2019 was USD 11.58 M, a -39.33% change year over year.
Key data
Date Free Cash Flow Operating Cash Flow Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities
Market news
Loading...
Stockholm Stock Exchange: BIOG-B.ST

BioGaia AB (publ)

CEO Ms. Theresa P. Agnew
IPO Date Jan. 3, 2000
Location Sweden
Headquarters Kungsbroplan 3
Employees 222
Sector Health Care
Industries
Description

BioGaia AB (publ) develops, markets, and sells probiotic products with documented health benefits worldwide. It operates through three segments: Pediatrics, Adult Health, and Other. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula. The Adult Health segment provides gut health tablets and oral health lozenges products, as well as cultures, which are used as an ingredient in a licensee's dairy product. The Other segment provides packaging solutions. The company offers its products in the areas of infantile colic and digestive health in children; antibiotic-associated and acute diarrhoea; gingivitis; periodontal disease; general health; Helicobacter pylori–the gastric ulcer bacterium; and low bone density. It offers its products under the BioGaia brand name. BioGaia AB (publ) was founded in 1990 and is headquartered in Stockholm, Sweden.

Similar companies

BIOT.ST

Biotage AB (publ)

USD 11.98

-2.51%

PROB.ST

Probi AB (publ)

USD 31.10

0.68%

EKTA-B.ST

Elekta AB (publ)

USD 5.39

-0.39%

SECT-B.ST

Sectra AB (publ)

USD 22.17

-0.20%

CEVI.ST

CellaVision AB (publ)

USD 18.76

3.89%

StockViz Staff

January 15, 2025

Any question? Send us an email